Additionally, combination therapies targeting apoptosis with other pathways are being tested for Parkinson’s and Alzheimer’s disease including antioxidants, cell cycle inhibitors, JNK inhibitors, GSK3β inhibitors, and STATINS [54], which could also be suitable strategy for delaying the progression of in SMA. Here, MAPK8 is linked to Parkinson disease.